Neopharm Announces Orphan Drug Application Filing For Il13-pe38qqr For The Treatment Of Idiopathic Pulmonary Fibrosis
Source: Medical News Today
Friday 12th March, 2010
NeoPharm, Inc. (Other OTC: NEOL.PK), announced that it has filed an orphan drug application with the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) to ha... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story